Related Experiment Videos
Mutagen sensitivity has high heritability: evidence from a twin study.
Xifeng Wu1, Margaret R Spitz, Christopher I Amos
1Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. xwu@mdanderson.org
Cancer Research
|June 17, 2006
Summary
Mutagen sensitivity, a known cancer predisposition, is highly heritable. This classic twin study confirms a significant genetic component influencing individual responses to mutagens, validating its role in cancer susceptibility.
Area of Science:
- Genetics
- Cancer Research
- Environmental Health
Background:
- Mutagen sensitivity is linked to cancer predisposition, but its heritability remains unclear.
- Understanding genetic and environmental influences on mutagen sensitivity is crucial for cancer risk assessment.
Purpose of the Study:
- To quantify the heritability of mutagen sensitivity using a classic twin study design.
- To investigate the contributions of genetic and environmental factors to mutagen sensitivity phenotypes.
Main Methods:
- Utilized a classic twin study design with 460 individuals, including monozygotic (MZ) and dizygotic (DZ) twins, and siblings.
- Measured mutagen sensitivity in peripheral blood lymphocytes following exposure to four distinct mutagens: bleomycin, benzo[a]pyrene diol epoxide, gamma-radiation, and 4-nitroquinoline-1-oxide.
- Applied biometric genetic modeling to analyze intraclass correlation coefficients and estimate heritability.
Main Results:
- Intraclass correlation coefficients for mutagen sensitivity were significantly higher in MZ twins compared to DZ twins and siblings.
- Biometric genetic modeling revealed substantial heritability estimates for sensitivity to different mutagens: 40.7% (bleomycin), 48.0% (benzo[a]pyrene diol epoxide), 62.5% (gamma-radiation), and 58.8% (4-nitroquinoline-1-oxide).
Conclusions:
- Mutagen sensitivity is a highly heritable trait, with significant genetic contributions influencing individual susceptibility.
- The findings strongly validate the use of mutagen sensitivity as a reliable biomarker for cancer susceptibility.
- This research provides robust evidence for the genetic basis of differential responses to mutagens, impacting cancer risk evaluation.